We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVG icon
1226
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.68B
$3.83M 0.01%
273,782
+3,098
+1% +$42.5K
AXTA icon
1227
Axalta
AXTA
$8.02B
$3.82M 0.01%
163,234
+10,859
+7% +$270K
OCSL icon
1228
Oaktree Specialty Lending
OCSL
$1.13B
$3.81M 0.01%
300,399
-302,320
-50% -$4.13M
EXAS
1229
DELISTED
Exact Sciences
EXAS
$3.81M 0.01%
60,342
-3,132
-5% -$215K
AUD
1230
DELISTED
Audacy, Inc.
AUD
$3.79M 0.01%
664,129
-61,642
-8% -$410K
RFFC icon
1231
ALPS Active Equity Opportunity ETF
RFFC
$30.8M
$3.77M 0.01%
129,766
+87,552
+207% +$2.84M
FUL icon
1232
H.B. Fuller
FUL
$3.36B
$3.77M 0.01%
88,235
-8,785
-9% -$398K
NEM icon
1233
Newmont
NEM
$123B
$3.75M 0.01%
108,302
+3,328
+3% +$108K
SCIU
1234
DELISTED
Global X Scientific Beta US ETF
SCIU
$3.75M 0.01%
134,286
-3,307
-2% -$102K
SBNY
1235
DELISTED
Signature Bank
SBNY
$3.75M 0.01%
36,434
-4,524
-11% -$509K
GNTX icon
1236
Gentex
GNTX
$5.05B
$3.74M 0.01%
185,096
-14,015
-7% -$294K
HZNP
1237
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.74M 0.01%
191,453
-15,936
-8% -$312K
MGU
1238
DELISTED
Macquarie Global Infrastructure Total Return Fund, Inc.
MGU
$3.74M 0.01%
198,786
+31,873
+19% +$639K
PPT
1239
Franklin Premier Income Trust
PPT
$329M
$3.74M 0.01%
796,588
+12,921
+2% +$63.9K
PTH icon
1240
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$244M
$3.73M 0.01%
157,317
-102,381
-39% -$2.76M
ESS icon
1241
Essex Property Trust
ESS
$18.2B
$3.73M 0.01%
15,197
+10,922
+255% +$2.75M
MAIN icon
1242
Main Street Capital
MAIN
$5.52B
$3.71M 0.01%
109,849
-13,286
-11% -$494K
BOE icon
1243
BlackRock Enhanced Global Dividend Trust
BOE
$691M
$3.71M 0.01%
395,506
+32,587
+9% +$329K
TXT icon
1244
Textron
TXT
$15.2B
$3.7M 0.01%
80,515
-77,641
-49% -$4.36M
CHX
1245
DELISTED
ChampionX
CHX
$3.7M 0.01%
136,609
+1,952
+1% +$71.8K
SINA
1246
DELISTED
Sina Corp
SINA
$3.69M 0.01%
68,854
+35,834
+109% +$2.21M
MUA icon
1247
BlackRock MuniAssets Fund
MUA
$519M
$3.69M 0.01%
286,643
+27,701
+11% +$355K
ALRM icon
1248
Alarm.com
ALRM
$2.77B
$3.68M 0.01%
70,971
+199
+0.3% +$9.62K
OLLI icon
1249
Ollie's Bargain Outlet
OLLI
$4.79B
$3.67M 0.01%
55,157
-18,006
-25% -$1.5M
TFLO icon
1250
iShares Treasury Floating Rate Bond ETF
TFLO
$6.72B
$3.66M 0.01%
+72,827
New +$3.66M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.